GlassScriptPhysician profile
Thomas Anthony Joseph
NPI 1700889490
$47,353.01
in general payments reported to CMS, 2019-2025
9 companies · $4,405 in 2025
The $4,405 reported for 2025 was more than what 81% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,155 · 2020: $14K · 2021: $151 · 2022: $308 · 2023: $18K · 2024: $1,351 · 2025: $4,405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,987.50 |
| Food and Beverage | $758.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $46,992.73 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Reversed II, Aequalis Perform |
| Smith+Nephew, INC. | $172.10 | 2020 | |
| Depuy Synthes Sales INC. | $54.10 | 2019-2022 | |
| Djo, LLC | $30.89 | 2023 | Aircast, Donjoy |
| Heron Therapeutics, INC. | $29.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.74 | 2020 | |
| Anika Therapeutics, INC. | $19.02 | 2021 | |
| Wright Medical Technology, INC. | $17.94 | 2019 | |
| Fx Shoulder Solutions, INC | $17.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.